Morgan Stanley’s Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) NHS.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-642,734
Closed -$5.14K 8713
2026
Q1
$5.14K Buy
+642,734
New +$5.59K ﹤0.01% 7126

Morgan Stanley's NHS.RT Position: Q2 2026 in Review

Morgan Stanley sold out of Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) (NHS.RT) in Q2 2026, closing a stake of 642,734 shares — an estimated $5.14K sold.

Morgan Stanley first reported a position in NHS.RT in Q1 2026 and held it in 1 quarter. The position peaked at $5.14K in Q1 2026. 0 funds tracked by Wall St. Rank hold NHS.RT as of Q2 2026.

  • Morgan Stanley reported no remaining Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 642,734 Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) shares in Q2 2026, an estimated $5.14K.
  • Morgan Stanley first reported a position in Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) in Q1 2026 and held it in 1 quarter.
  • Morgan Stanley's Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) position peaked at $5.14K in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.